NEUROMUSCULAR MANIFESTATIONS
Clinical trials for NEUROMUSCULAR MANIFESTATIONS explained in plain language.
Never miss a new study
Get alerted when new NEUROMUSCULAR MANIFESTATIONS trials appear
Sign up with your email to follow new studies for NEUROMUSCULAR MANIFESTATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CAR-T cells take on autoimmune muscle disease in first human trial
Disease control Recruiting nowThis early-phase study tests a new treatment called anitocabtagene autoleucel (anito-cel) for people with generalized myasthenia gravis, a condition that causes muscle weakness. Anito-cel is a type of CAR-T cell therapy that targets BCMA, a protein on certain immune cells. The st…
Matched conditions: NEUROMUSCULAR MANIFESTATIONS
Phase: PHASE1 • Sponsor: Arcellx, Inc. • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
New hope for SMA babies: drug trial aims to boost motor milestones
Disease control Recruiting nowThis study tests a drug called apitegromab in babies under 2 years old who have spinal muscular atrophy (SMA), a condition that weakens muscles. The goal is to see if the drug helps improve movement skills like rolling, sitting, and crawling. All participants must already be on s…
Matched conditions: NEUROMUSCULAR MANIFESTATIONS
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC